GemPharmatech Co

GemPharmatech Co EBIT per Share

The EBIT per Share of GemPharmatech Co (688046.SS) as of Oct 9, 2026 is 0.44 CNY. In the previous year, EBIT per Share was 0.30 CNY — a change of 48.74% (higher).

EBIT per Share

0.44CNY

YoY

48.74%

Last updated:

EBIT per Share of GemPharmatech Co is 2025 0.44 CNY. EBIT per Share of GemPharmatech Co was 2024 0.30 CNY. It decreases by 48.74% higher compared to the previous year.

The GemPharmatech Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
0.24 CNY
Jan 1, 2021
0.37 CNY
Jan 1, 2022
0.42 CNY
Jan 1, 2023
0.41 CNY
Jan 1, 2024
0.30 CNY
Jan 1, 2025
0.44 CNY
Jan 1, 2026 (e)
0.38 CNY
Jan 1, 2027 (e)
0.46 CNY
The GemPharmatech Co EBIT per Share history
YEAREBIT per ShareYoY
est0.46CNY+20.51%
est0.38CNY-13.42%
0.44CNY+48.74%
0.30CNY-26.45%
0.41CNY-3.07%
0.42CNY+13.97%
0.37CNY+54.18%
0.24CNY+96.76%
0.12CNY-2,973.09%
-0.00CNY—
Access this data via the Eulerpool API
Get Free API Key

GemPharmatech Co Stock analysis

What does GemPharmatech Co do? GemPharmatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GemPharmatech Co stock

EBIT per Share of GemPharmatech Co is 0.44 CNY in 2025.

EBIT per Share of GemPharmatech Co changed from 0.30 CNY to 0.44 CNY, representing a 48.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share GemPharmatech Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — GemPharmatech Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — GemPharmatech Co